Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $45.52 million. The enterprise value is $29.57 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 9.03 million shares outstanding. The number of shares has increased by 3.87% in one year.
| Current Share Class | 9.03M |
| Shares Outstanding | 9.03M |
| Shares Change (YoY) | +3.87% |
| Shares Change (QoQ) | +1.55% |
| Owned by Insiders (%) | 19.45% |
| Owned by Institutions (%) | 7.94% |
| Float | 7.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 267.78 |
| Forward PS | n/a |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 173.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.76
| Current Ratio | 5.76 |
| Quick Ratio | 5.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.53% and return on invested capital (ROIC) is -51.67%.
| Return on Equity (ROE) | -75.53% |
| Return on Assets (ROA) | -43.15% |
| Return on Invested Capital (ROIC) | -51.67% |
| Return on Capital Employed (ROCE) | -124.10% |
| Weighted Average Cost of Capital (WACC) | 11.25% |
| Revenue Per Employee | $6,538 |
| Profits Per Employee | -$637,923 |
| Employee Count | 26 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +110.88% in the last 52 weeks. The beta is 1.27, so LSTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +110.88% |
| 50-Day Moving Average | 3.93 |
| 200-Day Moving Average | 2.78 |
| Relative Strength Index (RSI) | 72.24 |
| Average Volume (20 Days) | 70,529 |
Short Selling Information
The latest short interest is 15,304, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 15,304 |
| Short Previous Month | 30,190 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, LSTA had revenue of $170,000 and -$16.59 million in losses. Loss per share was -$1.91.
| Revenue | 170,000 |
| Gross Profit | 170,000 |
| Operating Income | -18.21M |
| Pretax Income | -17.55M |
| Net Income | -16.59M |
| EBITDA | -18.06M |
| EBIT | -18.21M |
| Loss Per Share | -$1.91 |
Full Income Statement Balance Sheet
The company has $15.96 million in cash and n/a in debt, with a net cash position of $15.96 million or $1.77 per share.
| Cash & Cash Equivalents | 15.96M |
| Total Debt | n/a |
| Net Cash | 15.96M |
| Net Cash Per Share | $1.77 |
| Equity (Book Value) | 14.60M |
| Book Value Per Share | 1.68 |
| Working Capital | 14.63M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$15.95 million and capital expenditures -$28,000, giving a free cash flow of -$17.26 million.
| Operating Cash Flow | -15.95M |
| Capital Expenditures | -28,000 |
| Free Cash Flow | -17.26M |
| FCF Per Share | -$1.91 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -10,711.18% |
| Pretax Margin | -10,322.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.87% |
| Shareholder Yield | -3.87% |
| Earnings Yield | -36.43% |
| FCF Yield | -37.91% |
Analyst Forecast
The average price target for LSTA is $15.00, which is 197.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.00 |
| Price Target Difference | 197.62% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 125.82% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
LSTA has an Altman Z-Score of -42.9 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -42.9 |
| Piotroski F-Score | 1 |